Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_assertion type Assertion NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_head.
- NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_assertion description "[To investigate the impact of newly identified chromosome 3p21 epigenetic tumor suppressors PBRM1, SETD2, and BAP1 on cancer-specific survival (CSS) of 609 patients with clear cell renal cell carcinoma (ccRCC) from 2 distinct cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_provenance.
- NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_assertion evidence source_evidence_literature NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_provenance.
- NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_assertion SIO_000772 23620406 NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_provenance.
- NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_assertion wasDerivedFrom befree-20140225 NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_provenance.
- NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_assertion wasGeneratedBy ECO_0000203 NP545092.RAS44RejXcayBJkXXgb1v04DHfhlUVdRVkDP3ii-YtA6s130_provenance.